This inventor holds 4 USPTO granted patents. Top assignees: Boehringer Mannheim Gmbh, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 1995-1999.
Company Filing History:
3 out of 1,164 
1 out of 1,330 
Years Active: 1995-1999
Title: Carola Dony: Innovator in Recombinant Protein Activation
Introduction
Carola Dony is a notable inventor based in Starnberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of recombinant proteins. With a total of 4 patents to her name, her work has had a substantial impact on the scientific community.
Latest Patents
One of her latest patents is focused on methods for making Neisseria or Hemophilus IgA protease. This invention concerns a process for the isolation of recombinant IgA protease from inclusion bodies. Additionally, she has developed a recombinant DNA that codes for an IgA protease whose C-terminal helper sequence, and preferably also its N-terminal signal sequence, is no longer active. Another significant patent involves the activation of recombinant proteins that are present in at least a partially inactive form. In this process, a protein is activated using known solubilization and/or renaturation techniques, with the protein having additional helper sequences of 2 to 50 amino acids in length at its N- or C-terminus. The relative hydrophobicity of these helper sequences is calculated to have a negative numerical value.
Career Highlights
Carola Dony has worked with prominent companies in the biotechnology sector, including Boehringer Mannheim GmbH and Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. Her experience in these organizations has contributed to her expertise in recombinant protein research.
Collaborations
Throughout her career, Carola has collaborated with esteemed colleagues such as Gunter Schumacher and Dorothea Ambrosius. These partnerships have further enriched her research and innovations in the field.
Conclusion
Carola Dony's contributions to biotechnology, particularly in recombinant protein activation, highlight her role as an influential inventor. Her patents and collaborations reflect her commitment to advancing scientific knowledge and innovation.